{
  "abstract": "In nature, herding reflects adaptive responses to environmental pressure. In predator-dense African savannahs, animals herd defensively for protection. In resource-scarce deserts, herding occurs around limited resources. Herding in oncology drug development reflects these same evolutionary pressures: defensive clustering around promising targets to reduce risk.1 The analysis by Zhang and colleagues2 provides an empirical test of when this adaptive strategy becomes maladaptive.",
  "authors": [
    {
      "affiliations": [
        "The Kinghorn Cancer Centre, St Vincent’s Hospital, Sydney, NSW, Australia",
        "Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia",
        "Garvan Institute of Medical Research, Sydney, NSW, Australia"
      ],
      "name": "Jia Liu"
    },
    {
      "affiliations": [
        "Yale University Yale Cancer Center, New Haven, Connecticut, USA"
      ],
      "name": "Patricia LoRusso"
    }
  ],
  "title": "When herds overgraze: the cost of conformity in oncology drug development",
  "uid": "46c67611-04bf-57c2-b885-aca150f6da95"
}